[1]
Jumayev Mukhammadali Jakhongirovich, “The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance”, JELSI, vol. 4, no. 2, pp. 175–178, Feb. 2026.